↓ Skip to main content

Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases

Overview of attention for article published in CNS Drugs, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
1 news outlet
twitter
5 X users
patent
1 patent

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
82 Mendeley
Title
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
Published in
CNS Drugs, August 2019
DOI 10.1007/s40263-019-00657-9
Pubmed ID
Authors

Luke McAlary, Steven S. Plotkin, Neil R. Cashman

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 82 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 13%
Student > Ph. D. Student 11 13%
Student > Master 9 11%
Student > Bachelor 7 9%
Professor 4 5%
Other 11 13%
Unknown 29 35%
Readers by discipline Count As %
Medicine and Dentistry 9 11%
Neuroscience 8 10%
Biochemistry, Genetics and Molecular Biology 7 9%
Agricultural and Biological Sciences 3 4%
Social Sciences 3 4%
Other 14 17%
Unknown 38 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2024.
All research outputs
#2,606,507
of 25,605,018 outputs
Outputs from CNS Drugs
#215
of 1,395 outputs
Outputs of similar age
#51,869
of 354,260 outputs
Outputs of similar age from CNS Drugs
#1
of 14 outputs
Altmetric has tracked 25,605,018 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,395 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.7. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,260 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.